PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsPheochromocytoma
MeSH D010673 - pheochromocytoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010235:Paraganglioma
0 Companies
0 Drugs
Success rate
D010673: 
Pheochromocytoma
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPropranolol Propranolol  1987-10-07   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-12-01   
MylanPropranolol Propranolol  1985-11-19   
SandozPropranolol Propranolol  1988-07-05   
WyethPropranolol Inderal  1982-01-01   
Propranolol, Hydrochlorothiazide Inderide  1985-07-03   
Propranolol, Hydrochlorothiazide Inderide-  1982-01-01   
Bausch Health CompaniesMetyrosine Demser  1982-01-01   
Merck Sharp & DohmePropranolol Propranolol  1985-08-06   
Rising PharmaceuticalsPropranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1987-03-04   
Phenoxybenzamine Phenoxybenzamine  2023-06-20   
Zydus TherapeuticsPropranolol Propranolol  2011-03-25   
Warner ChilcottPropranolol Propranolol  1986-09-15   
Propranolol, Hydrochlorothiazide Propranolol Hydrochlorothiazide  1988-01-26   
Amneal PharmaceuticalsMetyrosine Metyrosine  2020-07-24   
Phenoxybenzamine Phenoxybenzamine  2020-10-27   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
62%
8/13
Phase 2
7%
2/29
Phase 3
45%
5/11
Approved: 3Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use